Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Davide

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Progress in Clinical and Biological Research|January 1, 1985
Studies on the expression of the amplified domain in human neuroblastoma cellsP W Melera, R W Michitsch, K T Montgomery, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1993
Negative growth selection against rodent fibroblasts targeted for genetic inhibition of farnesyl transferaseG C Prendergast, J P Davide, A Kral, et al.
The Journal of Biological Chemistry|November 10, 1982
Antifolate-resistant Chinese Hamster Cells. mRNA directed overproduction of multiple dihydrofolate reductases from a series of independently derived sublines containing amplified dihydrofolate reductase genesP W Melera, C A Hession, J P Davide, et al.
The Journal of Infectious Diseases|July 1, 1997
Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulinS M Lemon, P C Murphy, P J Provost, et al.
Vaccine|January 1, 1993
Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxisD Shouval, Y Ashur, R Adler, et al.
Molecular and Cellular Biology|June 1, 1994
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeletonG C Prendergast, J P Davide, S J deSolms, et al.
Journal of Hepatology|January 1, 1993
Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326FM E Armstrong, P A Giesa, J P Davide, et al.
Vaccine|January 1, 1992
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis AE F Ellerbeck, J A Lewis, D Nalin, et al.
Journal of Virology|August 1, 1990
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzeesE A Emini, P L Nara, W A Schleif, et al.
Science (New York, N.Y.)|August 24, 1990
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinantG J LaRosa, J P Davide, K Weinhold, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Progress in Clinical and Biological Research|January 1, 1985
Studies on the expression of the amplified domain in human neuroblastoma cellsP W Melera, R W Michitsch, K T Montgomery, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|September 1, 1993
Negative growth selection against rodent fibroblasts targeted for genetic inhibition of farnesyl transferaseG C Prendergast, J P Davide, A Kral, et al.
The Journal of Biological Chemistry|November 10, 1982
Antifolate-resistant Chinese Hamster Cells. mRNA directed overproduction of multiple dihydrofolate reductases from a series of independently derived sublines containing amplified dihydrofolate reductase genesP W Melera, C A Hession, J P Davide, et al.
The Journal of Infectious Diseases|July 1, 1997
Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulinS M Lemon, P C Murphy, P J Provost, et al.
Vaccine|January 1, 1993
Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxisD Shouval, Y Ashur, R Adler, et al.
Molecular and Cellular Biology|June 1, 1994
Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeletonG C Prendergast, J P Davide, S J deSolms, et al.
Journal of Hepatology|January 1, 1993
Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326FM E Armstrong, P A Giesa, J P Davide, et al.
Vaccine|January 1, 1992
Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis AE F Ellerbeck, J A Lewis, D Nalin, et al.
Journal of Virology|August 1, 1990
Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzeesE A Emini, P L Nara, W A Schleif, et al.
Science (New York, N.Y.)|August 24, 1990
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinantG J LaRosa, J P Davide, K Weinhold, et al.
Pageof 3